vs

Side-by-side financial comparison of Caledonia Mining Corp Plc (CMCL) and OptimizeRx Corp (OPRX). Click either name above to swap in a different company.

Caledonia Mining Corp Plc is the larger business by last-quarter revenue ($46.9M vs $32.2M, roughly 1.5× OptimizeRx Corp). OptimizeRx Corp runs the higher net margin — 15.6% vs 7.0%, a 8.6% gap on every dollar of revenue. On growth, Caledonia Mining Corp Plc posted the faster year-over-year revenue change (13.8% vs -0.2%). Over the past eight quarters, OptimizeRx Corp's revenue compounded faster (28.0% CAGR vs 17.1%).

Hochschild Mining plc is a leading British-based silver and gold mining business operating in North, Central, and South America. It is headquartered in Lima, Peru, with a corporate office in London, is listed on the London Stock Exchange and is a constituent of the FTSE 250 Index. The main shareholder is the Peruvian businessman Eduardo Hochschild.

OptimizeRx Corp is a U.S.-headquartered digital health technology company that delivers patient engagement, medication affordability and clinical communication solutions to life sciences enterprises, healthcare providers and pharmacy partners. Its core offerings include digital medication savings tools, patient support programs, and therapeutic area-specific resources to boost medication access and treatment adherence.

CMCL vs OPRX — Head-to-Head

Bigger by revenue
CMCL
CMCL
1.5× larger
CMCL
$46.9M
$32.2M
OPRX
Growing faster (revenue YoY)
CMCL
CMCL
+14.0% gap
CMCL
13.8%
-0.2%
OPRX
Higher net margin
OPRX
OPRX
8.6% more per $
OPRX
15.6%
7.0%
CMCL
Faster 2-yr revenue CAGR
OPRX
OPRX
Annualised
OPRX
28.0%
17.1%
CMCL

Income Statement — Q3 FY2024 vs Q4 FY2025

Metric
CMCL
CMCL
OPRX
OPRX
Revenue
$46.9M
$32.2M
Net Profit
$3.3M
$5.0M
Gross Margin
41.2%
74.8%
Operating Margin
18.6%
26.6%
Net Margin
7.0%
15.6%
Revenue YoY
13.8%
-0.2%
Net Profit YoY
-33.3%
6535.9%
EPS (diluted)
$0.13
$0.27

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CMCL
CMCL
OPRX
OPRX
Q4 25
$32.2M
Q3 25
$26.1M
Q2 25
$29.2M
Q1 25
$21.9M
Q4 24
$32.3M
Q3 24
$46.9M
$21.3M
Q2 24
$50.1M
$18.8M
Q1 24
$38.5M
$19.7M
Net Profit
CMCL
CMCL
OPRX
OPRX
Q4 25
$5.0M
Q3 25
$779.0K
Q2 25
$1.5M
Q1 25
$-2.2M
Q4 24
$-78.0K
Q3 24
$3.3M
$-9.1M
Q2 24
$10.2M
$-4.0M
Q1 24
$2.1M
$-6.9M
Gross Margin
CMCL
CMCL
OPRX
OPRX
Q4 25
74.8%
Q3 25
67.2%
Q2 25
63.8%
Q1 25
60.9%
Q4 24
68.1%
Q3 24
41.2%
63.1%
Q2 24
45.8%
62.2%
Q1 24
35.9%
62.0%
Operating Margin
CMCL
CMCL
OPRX
OPRX
Q4 25
26.6%
Q3 25
7.9%
Q2 25
10.9%
Q1 25
-9.6%
Q4 24
11.2%
Q3 24
18.6%
-40.2%
Q2 24
32.2%
-19.9%
Q1 24
13.8%
-25.5%
Net Margin
CMCL
CMCL
OPRX
OPRX
Q4 25
15.6%
Q3 25
3.0%
Q2 25
5.2%
Q1 25
-10.0%
Q4 24
-0.2%
Q3 24
7.0%
-42.8%
Q2 24
20.3%
-21.3%
Q1 24
5.4%
-35.0%
EPS (diluted)
CMCL
CMCL
OPRX
OPRX
Q4 25
$0.27
Q3 25
$0.04
Q2 25
$0.08
Q1 25
$-0.12
Q4 24
$0.00
Q3 24
$0.13
$-0.50
Q2 24
$0.42
$-0.22
Q1 24
$0.07
$-0.38

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CMCL
CMCL
OPRX
OPRX
Cash + ST InvestmentsLiquidity on hand
$7.2M
$23.4M
Total DebtLower is stronger
$26.3M
Stockholders' EquityBook value
$231.0M
$128.3M
Total Assets
$339.7M
$176.9M
Debt / EquityLower = less leverage
0.20×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CMCL
CMCL
OPRX
OPRX
Q4 25
$23.4M
Q3 25
$19.5M
Q2 25
$16.6M
Q1 25
$16.6M
Q4 24
$13.4M
Q3 24
$7.2M
$16.1M
Q2 24
$15.4M
Q1 24
$1.8M
Total Debt
CMCL
CMCL
OPRX
OPRX
Q4 25
$26.3M
Q3 25
$28.8M
Q2 25
$29.3M
Q1 25
$33.8M
Q4 24
$34.3M
Q3 24
$36.8M
Q2 24
$37.3M
Q1 24
$37.8M
Stockholders' Equity
CMCL
CMCL
OPRX
OPRX
Q4 25
$128.3M
Q3 25
$122.3M
Q2 25
$119.3M
Q1 25
$116.3M
Q4 24
$117.0M
Q3 24
$231.0M
$114.5M
Q2 24
$231.1M
$121.0M
Q1 24
$220.3M
$122.5M
Total Assets
CMCL
CMCL
OPRX
OPRX
Q4 25
$176.9M
Q3 25
$170.3M
Q2 25
$169.3M
Q1 25
$167.8M
Q4 24
$171.2M
Q3 24
$339.7M
$165.2M
Q2 24
$338.5M
$172.9M
Q1 24
$321.8M
$176.4M
Debt / Equity
CMCL
CMCL
OPRX
OPRX
Q4 25
0.20×
Q3 25
0.24×
Q2 25
0.25×
Q1 25
0.29×
Q4 24
0.29×
Q3 24
0.32×
Q2 24
0.31×
Q1 24
0.31×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CMCL
CMCL
OPRX
OPRX
Operating Cash FlowLast quarter
$4.6M
$7.1M
Free Cash FlowOCF − Capex
$7.1M
FCF MarginFCF / Revenue
22.0%
Capex IntensityCapex / Revenue
0.0%
Cash ConversionOCF / Net Profit
1.40×
1.41×
TTM Free Cash FlowTrailing 4 quarters
$18.7M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CMCL
CMCL
OPRX
OPRX
Q4 25
$7.1M
Q3 25
$3.2M
Q2 25
$4.6M
Q1 25
$3.9M
Q4 24
$198.0K
Q3 24
$4.6M
$1.8M
Q2 24
$19.1M
$782.0K
Q1 24
$2.1M
Free Cash Flow
CMCL
CMCL
OPRX
OPRX
Q4 25
$7.1M
Q3 25
$3.2M
Q2 25
$4.6M
Q1 25
$3.8M
Q4 24
$181.0K
Q3 24
$1.8M
Q2 24
$737.0K
Q1 24
$2.1M
FCF Margin
CMCL
CMCL
OPRX
OPRX
Q4 25
22.0%
Q3 25
12.2%
Q2 25
15.6%
Q1 25
17.5%
Q4 24
0.6%
Q3 24
8.3%
Q2 24
3.9%
Q1 24
10.6%
Capex Intensity
CMCL
CMCL
OPRX
OPRX
Q4 25
0.0%
Q3 25
0.0%
Q2 25
0.0%
Q1 25
0.1%
Q4 24
0.1%
Q3 24
0.1%
Q2 24
0.2%
Q1 24
0.2%
Cash Conversion
CMCL
CMCL
OPRX
OPRX
Q4 25
1.41×
Q3 25
4.11×
Q2 25
2.98×
Q1 25
Q4 24
Q3 24
1.40×
Q2 24
1.87×
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons